Novartis and US government reach agreement on lowering drug prices in the US
Novartis and US government reach agreement on lowering drug prices in the US
arcticnovartis
- Novartis agrees to take actions aimed at meeting US Administration priorities for drug pricing
- Additional Novartis medicines will be made available through direct-to-patient platforms in 2026
- Company remains committed to investing in markets that value innovation and implement policies that support broad and fast access to medicines